Moreover, our recent documentation of differential survival outcomes in ErbB2-overexpressing breast cancers associated with different phosphorylation patterns (Ouyang et al, 1999b, 2001) supports the notion of multiple signalling pathways governing tumour growth phenotypes. This evidence concerns the gene ERBB2 and breast carcinoma.